Health from grape by resveratrol: Review;Resveratrol ile üzümden gelen saǧlik

Turkiye Klinikleri Journal of Medical Sciences

Volumn 29, Issue 5, 2009, Pages 1273-1279

  Keskin, Nurhan ^a   Noyan, Tevfik ^b   Kunter, Birhan ^c  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Resveratrol; Vitis

Indexed keywords

RESVERATROL;

ALZHEIMER DISEASE; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CULTIVAR; DRUG STRUCTURE; DRUG SYNTHESIS; GRAPE; HEAT TOLERANCE; ISCHEMIC HEART DISEASE; MORTALITY; NONHUMAN; RISK REDUCTION; THROMBOCYTE AGGREGATION INHIBITION; WINE;

EID: 73449084466     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Bavaresco L., Vezzulli S. Stilben phytoalexin physiology in grapevine (Vitis spp.) as affected by viticultural factors. In: Govil JN, Singh, VK, Arunachalam, C, eds. Recent Progress in Medicinal Plants. Vol. 11. Drug Development from New Molecules. Houston: Studium Press; 2006. p.389-410.
2. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem 1997;30(2):91-113.
3. Zgoda-Pols JR, Freyer AJ, Killmer LB, Porter JR. Antimicrobial resveratrol tetramers from the stem bark of Vatica oblongifoliassp. oblongifolia. J Nat Prod 2002;65(11):1554-9.
4. Ito T, Akao Y, Yi H, Ohguchi K, Matsumoto K, Tanaka T, et al. Antitumor effect of resveratrol oligomers against human cancer cell lines and the molecular mechanism of apoptosis induced by vaticanol C. Carcinogenesis 2003;24(9):1489-97.
5. Liu JC, Chen JJ, Chan P, Cheng CF, Cheng TH. Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 2003;42(6):1198-205.
6. Tedesco I, Russo M, Russo P, Iacomino G, Russo GL, Carraturo A, et al. Antioxidant effect of red wine polyphenols on red blood cells. J Nutr Biochem 2000;11(2):114-9.
7. Zbikowska HM, Olas B. Antioxidants with carcinostatic activity (resveratrol, vitamin E and selenium) in modulation of blood platelet adhesion. J Physiol Pharmacol 2000;51(3):513-20.
8. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2001;28(1-2):55-9.
9. Creasy LL, Creasy MT. Grape chemistry and the significance of resveratrol: An overview. Pharm Biol 1998;36(Suppl 1):8-13.
10. Goldberg DM, Ng E, Yan J, Karumanchiri A, Soleas GJ, Diamandis EP. Regional differences in resveratrol isomer concentrations of wines from various cultivars. Jof Wine Research 1996;7(1):13-24.
11. Dong Z. Molecular mechanism of the chemopreventive effect of resveratrol. Mutat Res 2003;523-524:145-50.
12. Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Amer J Enol Vitic 1992;43(1):49-52.
13. Renaud S, de Lorgeril M.Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339(8808):1523-6.
14. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275(5297):218-20.
15. Moriartry JM, Harmon R, Leslie AW, Bessis R, Anne-Celine B, Marielle A, et al. Resveratrol content of two Californian table grape cultivars. Vitis 2001;40(1):43-4.
16. Kuhnle G, Spencer JP, Chowrimootoo G, Schroeter H, Debnam ES, Srai SK, et al. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun 2000;272(1):212-7.
17. Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian HM, et al. Resveratrol blocks interleukin-1 beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood 2003;102(3):987-95.
18. Hsieh TC, Juan G, Darzynkiewicz Z, Wu JM. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 1999;59(11):2596-601.
19. Liang YC, Tsai SH, Chen L, Lin-Shiau SY, Lin JK. Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem Pharmacol 2003;65(7):1053-60.
20. Li Y, Cao Z, Zhu H. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol Res 2006;53(1):6-15.
21. Basly JP, Lavier MC. Dietary phytoestrogens: potential selective estrogen enzyme modulators? Planta Med 2005;71(4):287-94.
22. Huang C, Ma WY, Goranson A, Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999;20(2):237-42.
23. She QB, Bode AM, Ma WY, Chen NY, Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 2001;61(4):1604-10.
24. Chun KS, Surh YJ. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem Pharmacol 2004;68(6):1089-100.
25. Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M, Ravagnan G. Effects of resveratrol on human immune cell function. Life Sci 2001;70(1):81-96.
26. Gusman J, Malonne H, Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 2001;22(8):1111-7.
27. Ignatowicz E, Baer-Dubowska W. Resveratrol, a natural chemopreventive agent against degenerative diseases. Pol J Pharmacol 2001;53(6):557-69.
28. Park JW, Choi YJ, Jang MA, Lee YS, Jun DY, Suh SI, et al. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett 2001;163(1):43-9.
29. Fulda S, Debatin KM. Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 2004;23(40):6702-11.
30. Narayanan BA, Narayanan NK, Stoner GD, Bullock BP. Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci 2002;70(15):1821-39.
31. Alles A, Alley K, Barrett JC, Buttyan R, Columbano A, Cope FO, et al. Apoptosis: a general comment. FASEB J 1991;5(8):2127-8.
32. Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 1998;421(3):277-9.
33. Bertelli AA, Giovannini L, Stradi R, Urien S, Tillement JP, Bertelli A. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp Clin Res 1998;24(1):51-5.
34. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol 1998;138(6):619-20.
35. Zhang Y, Jayaprakasam B, Seeram NP, Olson LK, DeWitt D, Nair MG. Insulin secretion and cyclooxygenase enzyme inhibition by cabernet sauvignon grape skin compounds. J Agric Food Chem 2004;52(2):228-33.
36. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275(5297):218-20.
37. Carbó N, Costelli P, Baccino FM, López-Soriano FJ, Argilés JM. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun 1999;254(3):739-43.
38. Mahady GB, Pendland SL. Resveratrol inhibits the growth of Helicobacter pylori in vitro. Am J Gastroenterol 2000;95(7):1849.
39. Mollerup S, Ovrebø S, Haugen A. Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int J Cancer 2001;92(1):18-25.
40. Nakagawa H, Kiyozuka Y, Uemura Y, Senzaki H, Shikata N, Hioki K, et al. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J Cancer Res Clin Oncol 2001;127(4):258-64.
41. Mahady GB, Pendland SL, Chadwick LR. Resveratrol and red wine extracts inhibit the growth of CagA+ strains of Helicobacter pylori in vitro. Am J Gastroenterol 2003;98(6):1440-1.
42. Ulsperger E, Hamilton G, Raderer M, Baumgartner G, Hejna M, Hoffmann O, et al. Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants. Int J Oncol 1999;15(5):955-9.
43. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341(8843):454-7.
44. Jäger U, Nguyen-Duong H. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries. Arzneimittelforschung 1999;49(3):207-11.
45. Delmas D, Jannin B, Latruffe N. Resveratrol: preventing properties against vascular alterations and ageing. Mol Nutr Food Res 2005;49(5):377-95.
46. Das S, Das DK. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2007;2(2):133-8.
47. Bertelli AA, Ferrara F, Diana G, Fulgenzi A, Corsi M, Ponti W, et al. Resveratrol, a natural stilbene in grapes and wine, enhances intraphagocytosis in human promonocytes: a co-factor in antiinflammatory and anticancer chemopreventive activity. Int J Tissue React 1999;21(4):93-104.
48. Lin JK, Tsai SH. Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc Repub China B 1999;23(3):99-106.
49. Wang MJ, Huang HM, Hsieh SJ, Jeng KC, Kuo JS. Resveratrol inhibits interleukin-6 production in cortical mixed glial cells under hypoxia/hypoglycemia followed by reoxygenation. J Neuroimmunol 2001;112(1-2):28-34.
50. Olas B, Wachowicz B, Saluk-Juszczak J, Zieliński T. Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin. Thromb Res 2002;107(3-4):141-5.
51. Kimura Y, Okuda H, Arichi S. Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 1985;834(2):275-8.
52. Bertelli AA, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M, et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 1995;17(1):1-3.
53. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995;235(2):207-19.
54. Kirk RI, Deitch JA, Wu JM, Lerea KM. Resveratrol decreases early signaling events in washed platelets but has little effect on platelet in whole blood. Blood Cells Mol Dis 2000;26(2):144-50.
55. Olas B, Wachowicz B, Saluk-Juszczak J, Zieliński T. Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin. Thromb Res 2002;107(3-4):141-5.
56. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem Pharm Bull (Tokyo) 1982;30(5):1766-70.
57. Kimura Y, Ohminami H, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of roots of Polygonum ssp. on liver injury in peroxidized oil-fed rats. Planta Med 1983;49(1):51-4.
58. Savaskan E, Olivieri G, Meier F, Seifritz E, Wirz-Justice A, Müller-Spann F. Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 2003;49(6):380-3.
59. Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 2005;280(45):37377-82.
60. Celotti E, Ferrarini R, Zironi R, Conte LS. Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J Chromatogr A 1996;730(1-2):47-52.
61. Hung LM, Su MJ, Chu WK, Chiao CW, Chan WF, Chen JK. The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol 2002;135(7):1627-33.
62. Cheong H, Ryu SY, Kim KM. Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Med 1999;65(3):266-8.
63. Jang M, Pezzuto JM. Assessment of cyclooxygenase inhibitors using in vitro assay systems. Methods Cell Sci 1997;19(1):25-31.
64. Ballmer PE. [The Mediterranean diet - healthy but and still delicious]. Ther Umsch 2000;57(3):167-72.
65. Huang SS, Tsai MC, Chih CL, Hung LM, Tsai SK. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 2001;69(9):1057-65.
66. Culpitt SV, Rogers DF, Fenwick PS, Shah P, De Matos C, Russell RE, et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 2003;58(11):942-6.
67. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003;425(6954):191-6.
68. Gruber J, Tang SY, Halliwell B. Evidence for a trade-off between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans. Ann N Y Acad Sci 2007;1100:530-42.
69. Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev 2007; 128 (10):546-52.
70. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 2006;16(3):296-300.
71. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444(7117):337-42.